Literature DB >> 29629482

Immunologist's Perspectives on Assessment and Management of Lung Disease in CVID: a Survey of the Membership of the Clinical Immunology Society and the European Society for Immunodeficiencies.

Javeed Akhter1, Cheryl A Lefaiver2, Christopher Scalchunes3, Michael DiGirolamo2, Klaus Warnatz4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29629482     DOI： 10.1007/s10875-018-0488-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  33 in total

1.  Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Authors:  B Bradley; H M Branley; J J Egan; M S Greaves; D M Hansell; N K Harrison; N Hirani; R Hubbard; F Lake; A B Millar; W A H Wallace; A U Wells; M K Whyte; M L Wilsher
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

2.  Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.

Authors:  P J Wills; T Wodehouse; K Corkery; K Mallon; R Wilson; P J Cole
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

3.  Abatacept therapy in rheumatoid arthritis with interstitial lung disease.

Authors:  Antonio Mera-Varela; Eva Pérez-Pampín
Journal:  J Clin Rheumatol       Date:  2014-12       Impact factor: 3.517

4.  Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group.

Authors:  A E O'Donnell; A F Barker; J S Ilowite; R B Fick
Journal:  Chest       Date:  1998-05       Impact factor: 9.410

5.  Primary Immunodeficiency Diseases: An Opportunity in Pediatrics for Improving Patient Outcomes.

Authors:  Vivian P Hernandez-Trujillo; Chris Scalchunes; Hillary S Hernandez-Trujillo; John Boyle; Paul Williams; Marcia Boyle; Jordan S Orange
Journal:  Clin Pediatr (Phila)       Date:  2015-03-15       Impact factor: 1.168

6.  Summary health statistics for the u.s. Population: national health interview survey, 2011.

Authors:  Patricia F Adams; Whitney K Kirzinger; Michael E Martinez
Journal:  Vital Health Stat 10       Date:  2012-12

Review 7.  New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.

Authors:  R Ameratunga; S-T Woon; D Gillis; W Koopmans; R Steele
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

8.  Pulmonologist perspectives regarding diagnosis and management of primary immunodeficiency diseases.

Authors:  Jordan S Orange; Javeed Akhter; Filiz O Seeborg; Marcia Boyle; Christopher Scalchunes; Vivian Hernandez-Trujillo
Journal:  Allergy Asthma Proc       Date:  2016-11       Impact factor: 2.587

9.  Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.

Authors:  James D Chalmers; Maeve P Smith; Brian J McHugh; Cathy Doherty; John R Govan; Adam T Hill
Journal:  Am J Respir Crit Care Med       Date:  2012-06-28       Impact factor: 21.405

10.  Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.

Authors:  Charles S Haworth; Juliet E Foweraker; Peter Wilkinson; Robert F Kenyon; Diana Bilton
Journal:  Am J Respir Crit Care Med       Date:  2014-04-15       Impact factor: 21.405
View more
  3 in total

1.  Use of FEF25-75% to Guide IgG Dosing to Protect Pulmonary Function in CVID.

Authors:  Tracy Hwangpo; Zhixin Wang; Jack Ghably; Surya P Bhatt; Xiangqin Cui; Harry W Schroeder
Journal:  J Clin Immunol       Date:  2020-01-03       Impact factor: 8.317

2.  Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey.

Authors:  Annick A J M van de Ven; Tiago M Alfaro; Alexandra Robinson; Ulrich Baumann; Anne Bergeron; Siobhan O Burns; Alison M Condliffe; Børre Fevang; Andrew R Gennery; Filomeen Haerynck; Joseph Jacob; Stephen Jolles; Marion Malphettes; Véronique Meignin; Tomas Milota; Joris van Montfrans; Antje Prasse; Isabella Quinti; Elisabetta Renzoni; Daiana Stolz; Klaus Warnatz; John R Hurst
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

3.  Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review.

Authors:  Erika Yue Lee; Stephen Betschel; Eyal Grunebaum
Journal:  Allergy Asthma Clin Immunol       Date:  2022-03-09       Impact factor: 3.406
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.